I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Distinct mechanisms of resistance to fulvestrant treatment ..:
Kamila Kaminska
;
Nina Akrap
;
Johan Staaf
...
https://doi.org/10.1186/s13058-021-01402-1. , 2021
Link:
https://doi.org/10.1186/s13058-021-01402-1
RT Journal T1
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:7cbcb174cf144b08807aab383e525e6b&Exemplar=1&LAN=DE A1 Kamila Kaminska A1 Nina Akrap A1 Johan Staaf A1 Carla L. Alves A1 Anna Ehinger A1 Anna Ebbesson A1 Ingrid Hedenfalk A1 Lukas Beumers A1 Srinivas Veerla A1 Katja Harbst A1 Sidse Ehmsen A1 Signe Borgquist A1 Åke Borg A1 Alejandro Pérez-Fidalgo A1 Henrik J. Ditzel A1 Ana Bosch A1 Gabriella Honeth PB BMC YR 2021 K1 Metastatic breast cancer K1 Endocrine treatment resistance K1 Cell cycle inhibitors K1 Fulvestrant K1 Cyclin E2 K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://doi.org/10.1186/s13058-021-01402-1 LK http://dx.doi.org/https://doi.org/10.1186/s13058-021-01402-1 DO https://doi.org/10.1186/s13058-021-01402-1 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)